Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elementis Chromium is a leading producer of chromium chemicals, specializing in the manufacture of sodium dichromate, chromic acid, and chromic oxide. Formerly a core business segment of the specialty chemicals company Elementis plc, it was the only domestic producer of these chemicals in the United States. The company's products serve a wide range of industrial applications, including metal finishing for medical instruments, aerospace components, and leather tanning. In January 2023, the business was acquired by the Yildirim Group for approximately $170 million as part of a strategic divestiture by its parent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elementis Chromium.